Cite
HARVARD Citation
Choi, I. et al. (n.d.). Angiotensin-Converting Enzyme Inhibitors Provide Better Long-Term Survival Benefits to Patients With AMI Than Angiotensin II Receptor Blockers After Survival Hospital Discharge. Journal of cardiovascular pharmacology and therapeutics. pp. 120-129. [Online].